Assessing the landscape of the pharma industry’s readiness for future pandemics by looking at past pandemics, funding and revenue, and sustainability.
Cameron Pott
Advertisement
Articles by Cameron Pott
Advertisement
Latest Updated Articles
- Commercial Sustainability of Pharmaceutical Innovations for Pandemics
September 30th 2020
Advertisement
Advertisement
Trending on PharmExec
1
Novo Nordisk Signs Deal with Hims & Hers
2
AI has Redefined Healthcare Communication — and There’s No Opting Out
3
Mergers and Acquisitions Roundup: GSK and Alfasigma Enter Licensing Agreement for Linerixibat, Servier Enters $2.5 Billion Definitive Agreement to Acquire Day One Pharmaceuticals
4
Pharmaceutical Executive Daily: Vinay Prasad Set to Leave CBER for Second Time
5